Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03447886 · ClinicalTrials.gov registry record
Understanding Barriers to Initiation and Adherence to Endocrine Therapy in Young Breast Cancer Survivors of Diverse Backgrounds
A clinical trial, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- 17
- Enrollment target
NCT03447886 is a clinical trial that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 17 participants.
The verdict
NCT03447886 has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
Study Summary
The overall goal of this study is to qualitatively explore how behavioral, cultural, psychosocial, and economic barriers and facilitators affect the decision to start and adhere to endocrine therapy (ET) among young breast cancer survivors of diverse racial, ethnic, and socio-economic backgrounds with hormone receptor positive (HR+) breast cancer
Interventions
- OTHER Phone interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2018-03-09 |
| Est. Completion | 2018-08-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03447886
The ClinicalTrials.gov registry entry for NCT03447886 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Phone interview is the first listed.
NCT03447886 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03447886 about?
NCT03447886 is a clinical study titled "Understanding Barriers to Initiation and Adherence to Endocrine Therapy in Young Breast Cancer Survivors of Diverse Backgrounds". The overall goal of this study is to qualitatively explore how behavioral, cultural, psychosocial, and economic barriers and facilitators affect the decision to start and adhere to endocrine therapy (ET) among young breast cancer survivors of diverse racial, ethnic, and socio-economic backgrounds wi...
What is the current status of trial NCT03447886?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2018-03-09. Estimated completion is 2018-08-27.
What interventions are being tested in trial NCT03447886?
The interventions under investigation include: Phone interview (OTHER).
Who is sponsoring clinical trial NCT03447886?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.